During the past decade, Hospital Padre Hurtado conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Padre Hurtado" #1 sponsor was "Mannkind Corporation" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "MedImmune LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Alios Biopharma Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Padre Hurtado" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hospital Padre Hurtado" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "The George Institute for Global Health, Australia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Padre Hurtado" are "Respiratory Syncytial Virus Infections" (3 trials), "COVID-19" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Acute Ischemic Stroke Patients Receiving Reperfusion Therapy" (1 trials) and "Benign Gallbladder Disease" (1 trials). Many other conditions were trialed in "Hospital Padre Hurtado" in a lesser frequency.

Most popular intervention types in "Hospital Padre Hurtado" are "Drug" (8 trials), "Biological" (6 trials), "Other" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Technosphere Insulin" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Padre Hurtado" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Padre Hurtado". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Padre Hurtado, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Padre Hurtado, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".